Market revenue in 2023 | USD 1,177.9 million |
Market revenue in 2030 | USD 1,967.4 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Ceramics & bioactive glass biomaterials |
Fastest growing segment | Polymers Biomaterials |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ceramics & Bioactive Glass Biomaterials, Polymers Biomaterials, Calcium Phosphate Cements, Metal Biomaterials, Composites |
Key market players worldwide | Koninklijke DSM NV, Evonik Industries AG, Stryker Corp, DePuy Synthes, Zimmer Biomet Holdings Inc, Globus Medical Inc Class A, Exactech, Matexcel, AdvanSource Biomaterials Corporation, Invibio, CAM Bioceramics, Heraeus |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic biomaterials market will help companies and investors design strategic landscapes.
Ceramics & bioactive glass biomaterials was the largest segment with a revenue share of 32.67% in 2023. Horizon Databook has segmented the UK orthopedic biomaterials market based on ceramics & bioactive glass biomaterials, polymers biomaterials, calcium phosphate cements, metal biomaterials, composites covering the revenue growth of each sub-segment from 2018 to 2030.
The UK orthopedic biomaterials market held the second largest revenue share of 16.4% in 2019 and is anticipated to be the fastest growing regional market over the forecast period. Key factors anticipated to drive the market growth are medical reimbursement available for orthopedic devices and surgeries in the country, owing to which citizens opt for replacement and correction surgeries.
This further creates a strong demand for orthopedic implants and biomaterials in the market. For instance, according to the National Joint Registry, in 2017, the total number of primary hip replacement surgeries and knee replacement surgeries in major countries of the UK, such as England, Wales, and Northern Ireland, were reported to be 91,698 and 102,177, respectively.
Furthermore, as per the article published in the Osteoarthritis and Cartilage journal in 2015, due to the increasing geriatric population in the UK, it was estimated that the NHS will need to perform around 439,097 hip replacement procedures and more than 1 million knee replacement surgeries by 2035. As the number of replacement surgeries are anticipated to increase over the forecast period, demand for orthopedic biomaterials is also expected to increase.
Horizon Databook provides a detailed overview of country-level data and insights on the UK orthopedic biomaterials market, including forecasts for subscribers. This country databook contains high-level insights into UK orthopedic biomaterials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account